Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial

Transactions of the American Ophthalmological Society

Volumn 102, Issue , 2004, Pages 233-250

  Good, William V ^a   Flynn, John T ^b   Flach, Allan J ^b   Cibis, Gerhard W ^b   Raab, Edward L ^b   Beauchamp, George R ^b  

^a SMITH KETTLEWELL EYE RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; CRYOTHERAPY; DISEASE COURSE; FEMALE; HIGH RISK POPULATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PATIENT SELECTION; PRIORITY JOURNAL; RANDOMIZATION; RETINA DETACHMENT SURGERY; RETROLENTAL FIBROPLASIA; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; TECHNIQUE; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL THRESHOLD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CRYOSURGERY; FOLLOW UP; LASER SURGERY; NEWBORN; PATHOLOGY; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; RETINA; RISK FACTOR; TIME;

CRYOSURGERY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; LASER SURGERY; MALE; RETINA; RETINOPATHY OF PREMATURITY; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 17244381522     PISSN: 15456110     EISSN: 15456110     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: ophthalmological outcomes at 10 years. Arch Ophthalmol 2001;119:1110-1118.
2. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: preliminary results. Arch Ophthalmol 1988;106:471-479.
3. Rescan Z, Vamos R, Salacz G. Laser treatment of zone I prethreshold and stage 3 threshold retinopathy of prematurity. J Ophthalmol Strabismus 2003;40:204-207.
4. Vander JF, Handa J, McNamara JA, et al. Early treatment of posterior retinopathy of prematurity: a controlled trial. Ophthalmology 1997;104:1731-1735; discussion 1735-1736.
5. Good WV, Hardy RJ, for the ETROP Multicenter Study Group. The multicenter study of early treatment for retinopathy of prematurity (ETROP) [guest editorial]. Ophthalmology 2001;108:1013-1014.
6. Early Treatment for Retinopathy of Prematurity Cooperative Group. Multicenter trial of Early Treatment for Retinopathy of Prematurity: study design. Contr Clin Trials 2004;25:311-325.
7. Hardy RJ, Palmer EA, Dobson V, et al. Risk analysis of prethreshold ROP. Arch Ophthalmol 2003;121:1699-1701.
8. Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol 2003;121:1684-1696.
9. McDonald MA, Dobson V, Series SL, et al. The acuity card procedure: a rapid test of infant acuity. Invest Ophthalmol Vis Sci 1985;26:1158-1162.
10. Teller DY, McDonald MA, Preston K, et al. Assessment of visual acuity in infants and children: the acuity card procedure. Dev Med Child Neurol 1986;28:779-789.
11. Dobson V, Quinn GE, Biglan AW, et al. Acuity card assessment of visual function in the cryotherapy for retinopathy of prematurity trial. Invest Ophthalmol Vis Sci 1990;31:1702-1708.
12. Trueb L, Evans J, Hammel A, et al. Assessing visual acuity of visually impaired children using the Teller acuity card procedure. Am Orthopt J 1992;42:149-154.
13. Salomão SR, Ventura DF. Large sample population age norms for visual acuities obtained with Vistech-Teller Acuity Cards. Invest Ophthalmol Vis Sci 1995; 36:657-670.
14. Mayer DL, Beiser AS, Warner AF, et al. Monocular acuity norms for the Teller Acuity Cards between ages one month and four years. Invest Ophthalmol Vis Sci 1995;36:671-685.
15. Dobson V, Quinn GE, Siatkowski RM, et al, for the Cryotherapy for Retinopathy of Prematurity Cooperative Group. Agreement between grating acuity at age 1 year and Snellen acuity at age 5.5 years in the preterm child. Invest Ophthalmol Vis Sci 1999;40:496-503.
16. Frankenburg WK, Dodds JB. The Denver developmental screening test. J Pediatr 1967;71:181-191.
17. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity. One-year outcome-structure and function. Arch Ophthalmol 1990;108:1408-1416.
18. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity. Snellen visual acuity and structural outcome at 5-1/2 years after randomization. Arch Ophthalmol 1996;114:417-424.
19. Hardy RJ, Davis BR. The design, analysis, and monitoring of an ophthalmological clinical trial. ASA Proceedings of the Biopharmaceutical Section 1989;248-253.
20. Committee for the Classification of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. Arch Ophthalmol 1984;102:1130-1134.
21. Cryotherapy for Retinopathy of Prematurity Cooperative Group. The natural ocular outcome of premature birth and retinopathy: status at 1 year. Arch Ophthalmol 1994;112:903-912.
22. Msall ME, Phelps DL, DiGaudio KM, et al, on behalf of the Cryotherapy for Retinopathy of Prematurity Cooperative Group. Severity of neonatal retinopathy of prematurity is predictive of neurodevelopmental functional outcome at age 5.5 years. Pediatrics 2000;106:998-1005.
23. Jacobson L, Fernell E, Broberger U, et al. Children with blindness due to retinopathy of prematurity: a populationbased study. Perinatal data, neurological and ophthalmological outcome. Dev Med Child Neurol 1998;40:155-159.
24. Palmer EA, Flynn JT, Hardy RJ, et al, for the Cryotherapy for Retinopathy of Prematurity Cooperative Group. Incidence and early course of retinopathy of prematurity. Ophthalmology 1991;98:1628-1640.
25. Ferris FL III, Kassoff A, Bresnick GH, et al. New visual acuity charts for clinical research. Am J Ophthalmol 1982;94:91-96